封面
市場調查報告書
商品編碼
1754015

2025 年至 2033 年上市後藥物警戒和醫療資訊市場報告(按類型、產品、最終用戶和地區)

Post-marketing Pharmacovigilance and Medical Information Market Report by Type, Product, End User, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球上市後藥物警戒與醫療資訊市場規模達 62 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 139 億美元,2025-2033 年期間的成長率 (CAGR) 為 9.04%。

上市後藥物警戒和醫療資訊是指藥品和醫療器材上市後對其安全性和有效性進行監測的實務。它包括收集、監測和預防新藥、新設備和新療法的不良反應。它透過闡明與益處相關的風險並駁斥虛假適應症,幫助保護患者免受不必要的傷害。此外,它還協助研究人員確定整個藥物製劑週期所需的措施。因此,上市後藥物警戒和醫療資訊在醫療保健行業中發揮重要作用,用於評估患者和醫務人員之間傳遞訊息的準確性。研究機構也用它來規範藥物安全指南。

上市後藥物警戒與醫療資訊市場趨勢:

全球老年人口的成長以及糖尿病、高血壓、失智症、心血管疾病和骨質疏鬆症等各種慢性疾病發生率的上升,是導致藥品消費增加的關鍵因素之一。此外,生活方式、呼吸道和心血管感染以及神經系統和腫瘤疾病的發生率不斷上升,也導致全球藥品銷售額不斷成長。這反過來又創造了積極的市場前景。同時,藥品不良反應 (ADR) 的發生率不斷上升,加上先進的 ADR 報告工具的運用,正在支撐市場的成長。此外,醫院、診所、實驗室和醫學研究中心的擴張也刺激了全球對藥品和醫療器材的需求。各國政府正在實施多項舉措,以改善醫療基礎設施和藥物警戒服務,並維護醫療資料庫,這些舉措正在增強市場的成長。此外,領先的市場參與者正專注於外包藥物警戒操作(PVO)並引入基於雲端的醫療資訊系統,以實現最佳準確性、成本效率、風險緩解、領域、改進的時間表和組織敏捷性,預計這將推動市場發展。

本報告回答的關鍵問題

  • 全球上市後藥物警戒與醫療資訊市場規模有多大? 2025-2033年全球上市後藥物警戒與醫療資訊市場的預期成長率為何?
  • 推動全球上市後藥物警戒與醫療資訊市場發展的關鍵因素有哪些?
  • COVID-19 對全球上市後藥物警戒與醫療資訊市場有何影響?
  • 全球上市後藥物警戒與醫療資訊市場依類型分為哪些類型?
  • 根據最終用戶,全球上市後藥物警戒和醫療資訊市場是如何分佈的?
  • 全球上市後藥物警戒和醫療資訊市場的主要區域有哪些?
  • 全球上市後藥物警戒和醫療資訊市場的主要參與者/公司有哪些?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:簡介

  • 概述
  • 主要行業趨勢

第5章:全球上市後藥物警戒與醫療資訊市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章:市場細分:依類型

  • 自發報道
  • 強化ADR報告
  • 針對性的自發性報告
  • 群組事件監控
  • EHR挖掘

第7章:市場區隔:依產品

  • 圖書
  • 網路媒體
  • 期刊

第8章:市場區隔:按最終用戶

  • 醫院
  • 研究組織

第9章:市場細分:依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔:依國家

第10章:SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章:價格分析

第 14 章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accenture Plc.
    • ArisGlobal
    • Cognizant Technology Solutions Corporation
    • Ergomed Plc
    • F. Hoffmann-La Roche Ltd.
    • Icon Plc
    • Parexel International Corporation
    • Pharmaceutical Product Development, Inc.
    • Wipro Ltd.
Product Code: SR112025A6454

The global post-marketing pharmacovigilance and medical information market size reached USD 6.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.9 Billion by 2033, exhibiting a growth rate (CAGR) of 9.04% during 2025-2033.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

Post-marketing Pharmacovigilance and Medical Information Market Trends:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

Key Market Segmentation:

Breakup by Type:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Breakup by Product:

  • Books
  • Online Media
  • Journals

Breakup by End User:

  • Hospitals
  • Research Organization

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Key Questions Answered in This Report

  • 1.How big is the global post-marketing pharmacovigilance and medical information market?
  • 2.What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2025-2033?
  • 3.What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
  • 4.What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
  • 5.What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
  • 6.What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
  • 7.What are the key regions in the global post-marketing pharmacovigilance and medical information market?
  • 8.Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Post-marketing Pharmacovigilance and Medical Information Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Spontaneous Reporting
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intensified ADR Reporting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Targeted Spontaneous Reporting
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cohort Event Monitoring
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 EHR Mining
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Books
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Online Media
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Journals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accenture Plc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ArisGlobal
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cognizant Technology Solutions Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ergomed Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 F. Hoffmann-La Roche Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Icon Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Wipro Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
  • Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
  • Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
  • Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
  • Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players